Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others


Programmed death 1 Ligand 1 expression in breast cancer and its association with patients' clinical parameters

Li Fei, Ren Yi, Wang Zhandong

Year : 2018| Volume: 14| Issue : 1 | Page no: 150-154

   This article has been cited by
1 Pilot Study: Immune Checkpoints Polymorphisms in Greek Primary Breast Cancer Patients
Nyanbol Kuol, Xu Yan, Vanessa Barriga, Jimsheena Karakkat, Stamatis Vassilaros, Ioannis Fyssas, Anastasios Tsimpanis, Sarah Fraser, Kulmira Nurgali, Vasso Apostolopoulos
Biomedicines. 2022; 10(8): 1827
[Pubmed]  [Google Scholar] [DOI]
2 The expression of programmed death-ligand 1 and its association with histopathological grade, stage of disease, and occurrence of metastasis in breast cancer
Agung Sindu Pranoto, Haryasena Haryasena, Prihantono Prihantono, Septiman Rahman, Daniel Sampepajung, Indra Indra, Salman Ardy Syamsu, Elridho Sampepajung, Berti Julian Nelwan, Muhammad Faruk, Andi Nilawati Usman
Breast Disease. 2021; 40(s1): S71
[Pubmed]  [Google Scholar] [DOI]
3 Resistance mechanisms to programmed cell death protein 1 and programmed death ligand 1 inhibitors
Parmida Sadat Pezeshki, Pouya Mahdavi Sharif, Nima Rezaei
Expert Opinion on Biological Therapy. 2021; : 1
[Pubmed]  [Google Scholar] [DOI]
4 Clinicopathological and prognostic significance of programmed cell death ligand 1 expression in patients diagnosed with breast cancer: meta-analysis
M G Davey, É J Ryan, M S Davey, A J Lowery, N Miller, M J Kerin
British Journal of Surgery. 2021; 108(6): 622
[Pubmed]  [Google Scholar] [DOI]
5 Determining Factors in the Therapeutic Success of Checkpoint Immunotherapies against PD-L1 in Breast Cancer: A Focus on Epithelial-Mesenchymal Transition Activation
Mariana Segovia-Mendoza, Susana Romero-Garcia, Cristina Lemini, Heriberto Prado-Garcia, francesca bianchi
Journal of Immunology Research. 2021; 2021: 1
[Pubmed]  [Google Scholar] [DOI]
6 Prognostic Role of PD-L1 Expression in Invasive Breast Cancer: A Systematic Review and Meta-Analysis
Magno Belém Cirqueira, Carolina Rodrigues Mendonça, Matias Noll, Leonardo Ribeiro Soares, Maria Auxiliadora de Paula Carneiro Cysneiros, Regis Resende Paulinelli, Marise Amaral Rebouças Moreira, Ruffo Freitas-Junior
Cancers. 2021; 13(23): 6090
[Pubmed]  [Google Scholar] [DOI]
7 In Vitro Examinations of Cell Death Induction and the Immune Phenotype of Cancer Cells Following Radiative-Based Hyperthermia with 915 MHz in Combination with Radiotherapy
Michael Hader, Simon Streit, Andreas Rosin, Thorsten Gerdes, Martin Wadepohl, Sander Bekeschus, Rainer Fietkau, Benjamin Frey, Eberhard Schlücker, Stephan Gekle, Udo S. Gaipl
Cells. 2021; 10(6): 1436
[Pubmed]  [Google Scholar] [DOI]
8 Overexpression of an Immune Checkpoint (CD155) in Breast Cancer Associated with Prognostic Significance and Exhausted Tumor-Infiltrating Lymphocytes: A Cohort Study
Yu-Chen Li, Quan Zhou, Qing-Kun Song, Rui-Bin Wang, Shuzhen Lyu, Xiudong Guan, Yan-Jie Zhao, Jiang-Ping Wu
Journal of Immunology Research. 2020; 2020: 1
[Pubmed]  [Google Scholar] [DOI]
9 NPM1 upregulates the transcription of PD-L1 and suppresses T cell activity in triple-negative breast cancer
Ge Qin, Xin Wang, Shubiao Ye, Yizhuo Li, Miao Chen, Shusen Wang, Tao Qin, Changlin Zhang, Yixin Li, Qian Long, Huabin Hu, Dingbo Shi, Jiaping Li, Kai Zhang, Qinglian Zhai, Yanlai Tang, Tiebang Kang, Ping Lan, Fangyun Xie, Jianjun Lu, Wuguo Deng
Nature Communications. 2020; 11(1)
[Pubmed]  [Google Scholar] [DOI]
10 Differences of the Immune Phenotype of Breast Cancer Cells after Ex Vivo Hyperthermia by Warm-Water or Microwave Radiation in a Closed-Loop System Alone or in Combination with Radiotherapy
Michael Hader, Deniz Pinar Savcigil, Andreas Rosin, Philipp Ponfick, Stephan Gekle, Martin Wadepohl, Sander Bekeschus, Rainer Fietkau, Benjamin Frey, Eberhard Schlücker, Udo S. Gaipl
Cancers. 2020; 12(5): 1082
[Pubmed]  [Google Scholar] [DOI]
11 Programmed Cell Death Ligand 1 in Breast Cancer: Technical Aspects, Prognostic Implications, and Predictive Value
Federica Miglietta, Gaia Griguolo, Valentina Guarneri, Maria Vittoria Dieci
The Oncologist. 2019; 24(11)
[Pubmed]  [Google Scholar] [DOI]


Read this article